Adaptimmune Therapeutics plc (ADAP) Social Stream



Adaptimmune Therapeutics plc (ADAP): $1.01

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ADAP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#139 of 351

in industry

ADAPTIMMUNE THERAPEUTICS PLC (ADAP) Price Targets From Analysts

Use the tables below to see what analysts covering ADAPTIMMUNE THERAPEUTICS PLC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-14 5 $17 $7 $10.333 $0.509 1930.06%
2022-02-23 5 $9 $7 $7.666 $0.509 1406.09%
2022-03-14 5 $9 $3 $6.333 $0.509 1144.2%
2022-05-17 5 $9 $2 $6 $0.509 1078.78%
2022-08-04 4 $9 $2 $6 $0.509 1078.78%
2022-09-09 4 $10 $2 $6 $0.509 1078.78%
2022-10-04 4 $10 $1.5 $4.5 $0.509 784.09%
2022-11-09 5 $10 $1.5 $5.875 $0.509 1054.22%
2022-11-14 6 $10 $3 $6.25 $0.509 1127.9%
2023-01-05 7 $10 $3 $6.666 $0.509 1209.63%
2023-03-06 6 $10 $3 $6 $0.509 1078.78%
2023-05-12 6 $10 $2 $5.8 $0.509 1039.49%
2023-08-10 7 $10 $1 $5 $0.509 882.32%
2023-11-08 7 $10 $1 $4.833 $0.509 849.51%

The Trend in the Analyst Price Target


ADAP's average price target has moved down $2.83 over the prior 21 months.

Over the past 44 weeks, ADAP's average upside potential has been 412.72%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-05 6 10 3 6.666 2.040 226.76%
2023-03-06 6 10 2 5.800 1.320 339.39%
2023-04-11 6 10 2 5.800 1.210 379.34%
2023-05-12 6 10 2 5.800 1.370 323.36%
2023-08-10 7 10 1 5.000 0.815 513.5%

ADAP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.14 4 0 2 1 1 7

The Trend in the Broker Recommendations


Over the past 13 months, ADAP's average broker recommendation rating worsened by 0.14.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ADAP has a greater upside potential (average analyst target price relative to current price) than 1746.31% of all US stocks.
  • ADAP has a higher average analyst price target than 101.39% of all US stocks.
  • ADAPTIMMUNE THERAPEUTICS PLC's variance in analysts' estimates is lower than -1508.9% of all US stocks.
  • ADAP has a higher number of analysts covering the stock than 491.44% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADAPTIMMUNE THERAPEUTICS PLC are OTLK, TTNP, and BCDA.

Make investment decisions regarding ADAP using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!